Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer.

Shigemizu, Daichi

Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. [electronic resource] - PLoS computational biology Feb 2012 - e1002347 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1553-7358

10.1371/journal.pcbi.1002347 doi


Breast Neoplasms--drug therapy
Computational Biology--methods
Databases, Factual
Drug Discovery
Drug Repositioning
Female
Gene Expression Profiling--methods
Humans
Leukemia, Myeloid--drug therapy
Male
Prostatic Neoplasms--drug therapy
Signal Transduction